Genomix Carl Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 21-06-2024
- Paid Up Capital ₹ 0.10 M
as on 21-06-2024
- Company Age 9 Year, 23 Days
- Last Filing with ROC 31 Mar 2023
- Revenue -97.00%
(FY 2020)
- Profit -170.44%
(FY 2020)
- Ebitda 102.58%
(FY 2020)
- Net Worth -88.49%
(FY 2020)
- Total Assets 37.86%
(FY 2020)
About Genomix Carl
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rama Sankara, Somasekharam Guthula, Bilhan Polavarapu, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24233AP2015PTC097794
- Company No.
097794
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Nov 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Cuddapah, Andhra Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Genomix Carl?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rama Sankara  | Director | 26-Nov-2015 | Current |
| Somasekharam Guthula | Director | 26-Nov-2015 | Current |
| Bilhan Polavarapu | Director | 26-Nov-2015 | Current |
| Ojasvi Polavarapu | Director | 26-Nov-2015 | Current |
Rathnagiri Polavarapu  | Director | 26-Nov-2015 | Current |
Financial Performance and Corporate Structure Insights of Genomix Carl.
Genomix Carl Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 97% decrease. The company also saw a substantial fall in profitability, with a 170.44% decrease in profit. The company's net worth observed a substantial decline by a decrease of 88.49%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Genomix Carl?
In 2020, Genomix Carl had a promoter holding of 75.50% and a public holding of 24.50%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Genomix Molecular Diagnostics Private LimitedActive 17 years 11 monthsBilhan Polavarapu and Rathnagiri Polavarapu are mutual person
_PRIVATE_LIMITED.webp)
Genomix Healthcare (India) Private LimitedActive 14 years 3 monthsOjasvi Polavarapu and Rathnagiri Polavarapu are mutual person
Andhra Pradesh Centre For Advanced Research On Livestock LimitedActive 16 years 1 monthRama Sankara and Somasekharam Guthula are mutual person
- Meat Development Corporation Of Andhrapradesh LimitedActive 6 years 6 months
Somasekharam Guthula is a mutual person
_PRIVATE_LIMITED.webp)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Genomix Carl?
Unlock and access historical data on people associated with Genomix Carl, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Genomix Carl, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genomix Carl's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
